Suppliers / Yangzhou Pharmaceutical

Yangzhou Pharmaceutical

China Updated 9 July 2026

Yangzhou Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
1
filings across 1 regulators

What they file, and where

Molecule Regulators Docs
Isoniazid US FDA 1
Isradipine US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
NAFDAC (NG) 1 None

Questions about Yangzhou Pharmaceutical

Does Yangzhou Pharmaceutical hold a US DMF or a CEP?
Yangzhou Pharmaceutical holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Yangzhou Pharmaceutical make?
2 molecules are on record against Yangzhou Pharmaceutical, including Isoniazid and Isradipine. Each links through to that molecule's full manufacturer list.
Where does Yangzhou Pharmaceutical file?
Filings are on record with NAFDAC (NG), 1 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Yangzhou Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability